Heron Therapeutics
HRTX
#7238
Rank
S$0.39 B
Marketcap
$2.63
Share price
3.59%
Change (1 day)
69.70%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.61

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.52. In 2022 the company made an earnings per share (EPS) of -$2.25 an increase over its 2021 EPS that were of -$2.93.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.61-28.74%
2022-$2.25-23.11%
2021-$2.93-10%
2020-$3.26-0%
2019-$3.261.21%
2018-$3.22-32.7%
2017-$4.78-19.34%
2016-$5.9354.76%
2015-$3.831.73%
2014-$3.76-16.23%
2013-$4.4991.67%
2012-$2.34-31.45%
2011-$3.42-27.06%
2010-$4.69-43.75%
2009-$8.34-57.33%
2008-$19.54-82.92%
2007-$114.3720.61%
2006-$94.82175.76%
2005-$34.39-21.43%
2004-$43.77100%
2003-$21.88-38.24%
2002-$35.43161.54%
2001-$13.55-106.46%
2000$209.572051.55%
1999$9.74839.73%
1998$1.04-105.48%
1997-$18.93-88.16%
1996-$159.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.69-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.18-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.12 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.04-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.15 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA